LGBT Cancer Project

Therapeutic Areas: Oncology | Hematology | Musculoskeletal | Family Medicine

Multiple Myeloma Clinical Trials

A listing of Multiple Myeloma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

UPDATED

Scottsdale Arizona 85054

A clinical trial seeking patients for a research study for the treatment of Haematological Malignancy, Multile Pyeolma (SAR650984)

California

UPDATED

Duarte California 91010

A clinical trial to evaluate treatments using Ixazomib, Lenalidomide and Dexamethasone for patients with Multiple Myeloma

UPDATED

Los Angeles California 90095

A clinical trial to evaluate treatments using MEDI7247 for patients with Acute Myeloid Leukemia, Multiple Myeloma or Diffuse Large B-cell Lymphoma

UPDATED

San Francisco California 94117

A clinical trial seeking patients for a research study for the treatment of Haematological Malignancy, Multile Pyeolma (SAR650984)

UPDATED

San Francisco California 94143

A clinical trial to evaluate treatments using Ixazomib, Lenalidomide and Dexamethasone for patients with Multiple Myeloma

Colorado

UPDATED

Aurora Colorado 80045

A clinical trial seeking patients for a Cancer treatment research study

UPDATED

Denver Colorado 80218

A clinical trial to evaluate treatments using MEDI7247 for patients with Acute Myeloid Leukemia, Multiple Myeloma or Diffuse Large B-cell Lymphoma

Georgia

UPDATED

Atlanta Georgia 30322

A clinical trial to evaluate treatments using Ixazomib, Lenalidomide and Dexamethasone for patients with Multiple Myeloma

UPDATED

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of Carfilzomib, Pomalidomide and Dexamethasone to evaluate Multiple Myeloma

Illinois

UPDATED

Chicago Illinois 60637

A clinical trial to evaluate treatments using Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone for patients with Multiple Myeloma

UPDATED

Chicago Illinois 60637-6613

A Phase 3 clinical study for patients with Relapsed or Refractory Multiple Myeloma

Indiana

UPDATED

Fort Wayne Indiana 46845

A Phase 3 clinical study for patients with Relapsed or Refractory Multiple Myeloma

Massachusetts

UPDATED

Boston Massachusetts 02114

A clinical trial to evaluate treatments using MEDI7247 for patients with Acute Myeloid Leukemia, Multiple Myeloma or Diffuse Large B-cell Lymphoma

Michigan

UPDATED

Detroit Michigan 48201

A clinical trial seeking patients for a research study for the treatment of Haematological Malignancy, Multile Pyeolma (SAR650984)

UPDATED

Detroit Michigan 48201

A clinical trial to evaluate treatments using Ixazomib, Lenalidomide and Dexamethasone for patients with Multiple Myeloma

Missouri

UPDATED

St. Louis Missouri 63110

A clinical trial seeking patients for a research study for the treatment of Haematological Malignancy, Multile Pyeolma (SAR650984)

UPDATED

St. Louis Missouri 62864

A clinical trial to evaluate treatments using Ixazomib, Lenalidomide and Dexamethasone for patients with Multiple Myeloma

UPDATED

St. Louis Missouri 63110

A clinical trial to evaluate treatments using MEDI7247 for patients with Acute Myeloid Leukemia, Multiple Myeloma or Diffuse Large B-cell Lymphoma

New Jersey

UPDATED

Hackensack New Jersey 07601

A clinical trial seeking patients for a research study for the treatment of Haematological Malignancy, Multile Pyeolma (SAR650984)

UPDATED

Hackensack New Jersey 07601

Patients are needed to participate in a clinical research study of Carfilzomib, Pomalidomide and Dexamethasone to evaluate Multiple Myeloma

New York

UPDATED

New York New York 10065

A clinical trial seeking patients for a Cancer treatment research study

North Carolina

UPDATED

Durham North Carolina 27707

A clinical trial seeking patients for a research study for the treatment of Haematological Malignancy, Multile Pyeolma (SAR650984)

UPDATED

Durham North Carolina 27710

Patients are needed to participate in a clinical research study of Carfilzomib, Pomalidomide and Dexamethasone to evaluate Multiple Myeloma

Ohio

UPDATED

Canton Ohio 44718

A clinical trial seeking patients for a research study for the treatment of Haematological Malignancy, Multile Pyeolma (SAR650984)

UPDATED

Canton Ohio 44718

A Phase 3 clinical study for patients with Relapsed or Refractory Multiple Myeloma

UPDATED

Columbus Ohio 43210

A clinical trial to evaluate treatments using Ixazomib, Lenalidomide and Dexamethasone for patients with Multiple Myeloma

South Carolina

UPDATED

Charleston South Carolina 29414

A Phase 3 clinical study for patients with Relapsed or Refractory Multiple Myeloma

Tennessee

UPDATED

Nashville Tennessee 37232

A clinical trial seeking patients for a research study for the treatment of Haematological Malignancy, Multile Pyeolma (SAR650984)

UPDATED

Nashville Tennessee 37203

A clinical trial to evaluate treatments using Ixazomib, Lenalidomide and Dexamethasone for patients with Multiple Myeloma

UPDATED

Nashville Tennessee 37203

A clinical trial to evaluate treatments using MEDI7247 for patients with Acute Myeloid Leukemia, Multiple Myeloma or Diffuse Large B-cell Lymphoma

Texas

UPDATED

Houston Texas 77030

A clinical trial seeking patients for a Cancer treatment research study

UPDATED

Houston Texas 77030

A clinical trial seeking patients for a research study for the treatment of Myeloma

UPDATED

Houston Texas 77030

Patients are needed to participate in a clinical research study of Carfilzomib, Pomalidomide and Dexamethasone to evaluate Multiple Myeloma

UPDATED

Houston Texas 77030

Patients are needed to participate in a clinical research study to evaluate Myeloma, Autologous Stem Cell Transplant (ASCT)

UPDATED

San Antonio Texas 78229

A clinical trial to evaluate treatments using MEDI7247 for patients with Acute Myeloid Leukemia, Multiple Myeloma or Diffuse Large B-cell Lymphoma

Utah

UPDATED

Salt Lake City Utah 84112-5550

A clinical trial seeking patients for a research study for the treatment of Haematological Malignancy, Multile Pyeolma (SAR650984)

Washington

UPDATED

Seattle Washington 98109

Patients are needed to participate in a clinical research study of Carfilzomib, Pomalidomide and Dexamethasone to evaluate Multiple Myeloma

Wisconsin

UPDATED

Milwaukee Wisconsin 53226

A clinical trial seeking patients for a research study for the treatment of Haematological Malignancy, Multile Pyeolma (SAR650984)

Australia

UPDATED

Adelaide South Australia 5000

A Phase 3 clinical study for patients with Relapsed or Refractory Multiple Myeloma

UPDATED

East Melbourne Victoria 3002

A clinical trial seeking patients for a Cancer treatment research study

UPDATED

East Melbourne Victoria 3002

A Phase 3 clinical study for patients with Relapsed or Refractory Multiple Myeloma

UPDATED

Fitzroy, VIC Victoria 3065

A Phase 3 clinical study for patients with Relapsed or Refractory Multiple Myeloma

UPDATED

Geelong Victoria 3220

A Phase 3 clinical study for patients with Relapsed or Refractory Multiple Myeloma

UPDATED

Herston Queensland 4029

A Phase 3 clinical study for patients with Relapsed or Refractory Multiple Myeloma

UPDATED

Melbourne Victoria 3004

A Phase 3 clinical study for patients with Relapsed or Refractory Multiple Myeloma

UPDATED

Westmead New South Wales 2145

A Phase 3 clinical study for patients with Relapsed or Refractory Multiple Myeloma

Canada

UPDATED

Ottawa Ontario K1H 8L6

A Phase 3 clinical study for patients with Relapsed or Refractory Multiple Myeloma

UPDATED

Sherbrooke J1H5N4

A clinical research study of Isatuximab SAR650984 and REGN2810 for the treatment of Plasma Cell Myeloma

France

UPDATED

Pessac Cedex 33604

A clinical trial seeking patients for a research study for the treatment of Haematological Malignancy, Multile Pyeolma (SAR650984)

UPDATED

Pierre Benite 69310

A clinical trial seeking patients for a research study for the treatment of Haematological Malignancy, Multile Pyeolma (SAR650984)